FIC Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
FIC Capital's BMY Position: Q3 2017 in Review
FIC Capital reduced its Bristol-Myers Squibb (BMY) stake by 0.29% in Q3 2017, selling an estimated $1.46K and leaving 8,740 shares worth $557K. The position accounts for 0.21% of the portfolio, ranked #86.
FIC Capital first reported a position in BMY in Q2 2013 and has held it in 18 quarters since. The position peaked at $1.1M in Q2 2016. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.
- FIC Capital held 8,740 shares of Bristol-Myers Squibb worth $557K as of Q3 2017.
- FIC Capital sold 25 Bristol-Myers Squibb shares in Q3 2017, an estimated $1.46K.
- Bristol-Myers Squibb made up 0.21% of FIC Capital's portfolio in Q3 2017, its #86 holding.
- FIC Capital first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 18 quarters since.
- FIC Capital's Bristol-Myers Squibb position peaked at $1.1M in Q2 2016.
- 1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.
Based on FIC Capital's 13F filing for Q3 2017, filed 14 Nov 2017.